Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
Saved in:
Main Authors: | Saket Jha, GSRSNK Naidu, Aman Sharma |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-01-01
|
Series: | Indian Journal of Rheumatology |
Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=1;spage=4;epage=6;aulast=Jha |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment With Avacopan in Patients With Respiratory Tract Manifestations of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
by: Ulrich Specks, et al.
Published: (2025-01-01) -
Clinical Images: Propylthiouracil‐induced antineutrophil cytoplasmic antibody–associated vasculitis with aortic wall thickening
by: Sho Ishigaki, et al.
Published: (2025-01-01) -
Comments on: Antineutrophil cytoplasmic autoantibody associated vasculitis-Clinical profile and outcomes
by: Rohini Handa
Published: (2018-01-01) -
Systemic Lupus Erythematosus (SLE) and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis (AAV) Overlap Syndrome: Case Report and Review of the Literature
by: Sathish Itikyala, et al.
Published: (2019-01-01) -
A Case of Systemic Lupus Erythematosus/Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome with Dissociated Pathological and Immunological Findings
by: Kazuhiko Kato, et al.
Published: (2020-01-01)